Men's health

On June 14, 2010 Food and Drug Administration USA (FDA) approved drug Jalyn (dutasteride 0.5 mg and tamsulosin 0.4 mg) for the treatment of benign prostatic hyperplasia (BPH) in men with prostate enlargement.
Dutasteride is an inhibitor of 5α-reductase, tamsulosin is α1-adrenoceptor blocker. The combination

of dutasteride and tamsulosin has been properly studied in patients with BPH and it was shown high effectiveness and safety profile.

US Food and Drug Administration approved  generic tamsulosin HCl 0.4 mg capsule (Impax Laboratories; Flomax, Astellas Pharma, distributor Boehringer Ingelheim Pharmaceuticals).

Tamsulosin is currently marketed under the brand name Flomax.

Generic Tamsulosin is selective alpha-adrenergic blocker used to treat benign prostatic hyperplasia – one of the most common urological disease among men over 40 years of age.